A recent study explains that while SSRIs are found in the blood of many adolescent suicides, this is not a causal relationship. Read about the association here.

Will the FDA repeal its antidepressant warning label? Read more about its position and desire to evoke caution without inspiring fear.

Read the study abstract, and learn more about the research that found that antidepressant warning labels evoke caution, not panic. Full-text links on the right.

Read the press release behind the FDA's decision to put warning labels on antidepressants. Unlike many predictions, it seems the warning evoked caution, but not "black box panic."

While the "black box" warning has been on antidepressants for a few years, it seems that the warning has not adversely affected prescription rates.

An earlier study found that suicide risk decreased with treatment and questioned the connection found on antidepressant warning labels. They might still evoke caution in patients, but the medications are working.

Research indicates that even in children, suicides are decreased with SSRI drugs. While the antidepressant warning labels evoke caution, the medicines appear to work for young people.

Antidepressant warning labels are evoking caution in the psychiatric community, and fewer antidepressant medications have been offered to young people. The new research indicates that might not be the best approach.